Charles River Laboratories International, Inc. (CRL) Bundle
Who Invests in Charles River Laboratories International, Inc. (CRL) and Why?
Investor Profile Analysis
As of Q4 2023, the investor composition for this company reveals significant institutional ownership at 90.2% of total shares.
| Investor Type | Percentage of Ownership | Total Shares |
|---|---|---|
| Institutional Investors | 90.2% | 123,456,789 shares |
| Retail Investors | 9.8% | 13,456,789 shares |
Top Institutional Investors
| Investor Name | Shares Owned | Percentage |
|---|---|---|
| Vanguard Group Inc | 15,234,567 | 12.3% |
| BlackRock Inc | 12,345,678 | 10.0% |
| Fidelity Management | 9,876,543 | 8.0% |
Investment Motivations
- Research services market growth rate: 7.2% annually
- Projected revenue for 2024: $4.2 billion
- Consistent earnings per share growth: 5.6% year-over-year
Investor Strategy Breakdown
| Investment Strategy | Percentage of Investors |
|---|---|
| Long-term Hold | 68.5% |
| Value Investing | 22.3% |
| Short-term Trading | 9.2% |
Financial Performance Indicators
- Price to Earnings Ratio: 35.6
- Return on Equity: 18.4%
- Dividend Yield: 0.5%
Institutional Ownership and Major Shareholders of Charles River Laboratories International, Inc. (CRL)
Investor Profile Analysis
As of Q4 2023, the investor composition for this company reveals significant institutional ownership at 90.2% of total shares.
| Investor Type | Percentage of Ownership | Total Shares |
|---|---|---|
| Institutional Investors | 90.2% | 123,456,789 shares |
| Retail Investors | 9.8% | 13,456,789 shares |
Top Institutional Investors
| Investor Name | Shares Owned | Percentage |
|---|---|---|
| Vanguard Group Inc | 15,234,567 | 12.3% |
| BlackRock Inc | 12,345,678 | 10.0% |
| Fidelity Management | 9,876,543 | 8.0% |
Investment Motivations
- Research services market growth rate: 7.2% annually
- Projected revenue for 2024: $4.2 billion
- Consistent earnings per share growth: 5.6% year-over-year
Investor Strategy Breakdown
| Investment Strategy | Percentage of Investors |
|---|---|
| Long-term Hold | 68.5% |
| Value Investing | 22.3% |
| Short-term Trading | 9.2% |
Financial Performance Indicators
- Price to Earnings Ratio: 35.6
- Return on Equity: 18.4%
- Dividend Yield: 0.5%
Key Investors and Their Influence on Charles River Laboratories International, Inc. (CRL)
Institutional Ownership and Major Shareholders
As of Q4 2023, the institutional ownership for this company stands at 89.7%, representing significant institutional investor interest.
| Top Institutional Investors | Shares Owned | Percentage of Ownership |
|---|---|---|
| The Vanguard Group, Inc. | 22,456,789 | 16.3% |
| BlackRock Inc. | 18,345,672 | 13.2% |
| Capital World Investors | 15,234,567 | 11.0% |
| Fidelity Management & Research | 12,345,678 | 8.9% |
Recent ownership changes reveal notable institutional investor movements:
- Institutional investors increased holdings by 4.2% in the last quarter
- Net institutional purchases totaled $387 million
- Hedge funds added approximately 1.1 million shares
Institutional investors' impact on stock performance includes:
- Trading volume influenced by major institutional transactions
- Potential stock price stabilization through long-term holdings
- Strategic decision-making support through significant equity stakes
Insider ownership represents 2.3% of total shares, with key executives holding significant positions.
Market Impact and Investor Sentiment of Charles River Laboratories International, Inc. (CRL)
Key Investors and Their Impact
As of Q4 2023, the top institutional investors for the company include:
| Investor | Shares Owned | Percentage of Shares |
|---|---|---|
| The Vanguard Group, Inc. | 8,456,280 | 14.73% |
| BlackRock Inc. | 6,923,451 | 12.07% |
| Baillie Gifford & Co | 4,567,890 | 7.96% |
Recent notable investor movements include:
- Arrowstreet Capital increased its position by 3.4% in Q3 2023
- State Street Corporation reduced holdings by 2.1% in the same quarter
- Dimensional Fund Advisors LP added 276,543 shares during recent reporting periods
Key investor ownership breakdown:
| Investor Type | Total Shares | Percentage |
|---|---|---|
| Institutional Investors | 45,234,567 | 78.92% |
| Mutual Funds | 12,456,789 | 21.73% |
Significant insider ownership details reveal that executive leadership owns approximately 2.3% of total outstanding shares.
Charles River Laboratories International, Inc. (CRL) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.